Portage Biotech P/E Ratio

Portage Biotech (PRTG) currently reports a P/E ratio of -0.01. That is below the Energy sector average of 19.86. Use the charts on this page to explore Portage Biotech's P/E ratio history and peer comparisons.

Portage Biotech's P/E ratio of -0.01 is lower than the Energy sector average of 19.86. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Portage Biotech's market price to a fundamental measure such as earnings, sales, or book value. At -0.01, PRTG can look expensive or cheap only in context — versus its own history, growth rate, and Energy peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.01, then check the historical chart for trend and the peer comparison chart for relative positioning. The Energy average is 19.86. From there, open related valuation or income-statement pages for Portage Biotech, and consider following PRTG for alerts when major investors trade the stock.

Portage Biotech is classified in the Energy sector. On P/E ratio, it currently shows -0.01 versus a sector average near 19.86. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Energy are usually more informative than comparing PRTG with unrelated industries.